A detailed history of State Of Wyoming transactions in Eli Lilly & CO stock. As of the latest transaction made, State Of Wyoming holds 805 shares of LLY stock, worth $640,514. This represents 0.11% of its overall portfolio holdings.

Number of Shares
805
Previous 840 4.17%
Holding current value
$640,514
Previous $760,000 6.18%
% of portfolio
0.11%
Previous 0.13%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $27,024 - $33,600
-35 Reduced 4.17%
805 $713,000
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $46,391 - $58,178
-64 Reduced 7.08%
840 $760,000
Q1 2024

May 13, 2024

SELL
$592.2 - $792.28 $14,805 - $19,807
-25 Reduced 2.69%
904 $703,000
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $160,708 - $189,453
306 Added 49.12%
929 $541,000
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $4,347 - $5,993
-10 Reduced 1.58%
623 $334,000
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $221,667 - $296,395
632 Added 63200.0%
633 $296,000
Q1 2023

May 12, 2023

SELL
$310.63 - $364.82 $358,467 - $421,002
-1,154 Reduced 99.91%
1 $0
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $371,068 - $432,369
1,154 Added 115400.0%
1,155 $422,000
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $186,485 - $212,520
-629 Reduced 99.84%
1 $0
Q2 2022

Aug 15, 2022

SELL
$278.73 - $327.27 $203,751 - $239,234
-731 Reduced 53.71%
630 $204,000
Q1 2022

May 13, 2022

BUY
$234.69 - $291.66 $120,395 - $149,621
513 Added 60.5%
1,361 $390,000
Q4 2021

Feb 11, 2022

SELL
$224.85 - $279.04 $449 - $558
-2 Reduced 0.24%
848 $234,000
Q3 2021

Feb 11, 2022

BUY
$221.6 - $272.71 $111,021 - $136,627
501 Added 143.55%
850 $196,000
Q2 2021

Feb 11, 2022

SELL
$180.55 - $233.54 $98,038 - $126,812
-543 Reduced 60.87%
349 $80,000
Q1 2021

Feb 08, 2022

BUY
$164.32 - $212.72 $146,573 - $189,746
892 New
892 $167,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track State Of Wyoming Portfolio

Follow State Of Wyoming and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wyoming with notifications on news.